These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 8813470

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Medical treatment of digestive neuroendocrine tumours].
    Panzuto F, Nasoni S, Delle Fave G.
    Minerva Endocrinol; 2001 Sep; 26(3):145-8. PubMed ID: 11753237
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
    Schillaci O, Scopinaro F, Angeletti S, Tavolaro R, Danieli R, Annibale B, Gualdi G, Delle Fave G.
    J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
    [Abstract] [Full Text] [Related]

  • 28. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
    Dörr U, Räth U, Sautter-Bihl ML, Guzman G, Bach D, Adrian HJ, Bihl H.
    Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors.
    Kölby L, Wängberg B, Ahlman H, Tisell LE, Fjälling M, Forssell-Aronsson E, Nilsson O.
    World J Surg; 1998 Jul; 22(7):679-83. PubMed ID: 9606281
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
    Jamar F, Fiasse R, Leners N, Pauwels S.
    J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Peptide receptor imaging and therapy.
    Kwekkeboom D, Krenning EP, de Jong M.
    J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.